ATE467124T1 - Mit prp sp sc/sp wechselwirkende moleküle und deren verwendung - Google Patents
Mit prp sp sc/sp wechselwirkende moleküle und deren verwendungInfo
- Publication number
- ATE467124T1 ATE467124T1 AT03754894T AT03754894T ATE467124T1 AT E467124 T1 ATE467124 T1 AT E467124T1 AT 03754894 T AT03754894 T AT 03754894T AT 03754894 T AT03754894 T AT 03754894T AT E467124 T1 ATE467124 T1 AT E467124T1
- Authority
- AT
- Austria
- Prior art keywords
- prp
- molecules interacting
- sup
- peptides
- features
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000024777 Prion disease Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/256,538 US20040072236A1 (en) | 2002-09-27 | 2002-09-27 | PrPSc -interacting molecules and uses thereof |
PCT/US2003/030273 WO2004029072A2 (en) | 2002-09-27 | 2003-09-25 | PrPsc -INTERACTING MOLECULES AND USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE467124T1 true ATE467124T1 (de) | 2010-05-15 |
Family
ID=32041771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03754894T ATE467124T1 (de) | 2002-09-27 | 2003-09-26 | Mit prp sp sc/sp wechselwirkende moleküle und deren verwendung |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040072236A1 (de) |
EP (1) | EP1575989B1 (de) |
JP (1) | JP4533750B2 (de) |
AT (1) | ATE467124T1 (de) |
CA (1) | CA2500120A1 (de) |
DE (1) | DE60332488D1 (de) |
WO (1) | WO2004029072A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041807B1 (en) | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
US20050026165A1 (en) * | 2001-05-31 | 2005-02-03 | Cindy Orser | Detection of conformationally altered proteins and prions |
US7166471B2 (en) | 2001-05-31 | 2007-01-23 | Arete Associates | Misfolded protein sensor method in body fluids |
US20040072236A1 (en) | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
AU2004229535A1 (en) * | 2003-04-14 | 2004-10-28 | Pathogen Removal And Diagnostic Technologies, Inc. | Method for identifying ligands specific for structural isoforms of proteins |
US20060035242A1 (en) * | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
EP1653844B1 (de) | 2003-08-13 | 2012-12-12 | Novartis Vaccines and Diagnostics, Inc. | Prion-spezifische peptid-reagenzien |
US20060057671A1 (en) * | 2004-09-10 | 2006-03-16 | Orser Cindy S | Immobilized probes and methods of detecting conformationally altered prion proteins |
US7328063B2 (en) * | 2004-11-30 | 2008-02-05 | Cardiac Pacemakers, Inc. | Method and apparatus for arrhythmia classification using atrial signal mapping |
JP5162250B2 (ja) * | 2005-01-13 | 2013-03-13 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | プリオン特異的ペプチド試薬を使用するelisaアッセイ |
WO2006076683A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Isolation and detection of pathogenic prions |
ATE528649T1 (de) * | 2005-02-15 | 2011-10-15 | Adlyfe Inc | Verfahren zum nachweis falsch gefalteter proteine und prionen |
KR20080048527A (ko) * | 2005-09-09 | 2008-06-02 | 노파르티스 아게 | 프리온-특이적 펩토이드 시약 |
JP4769925B2 (ja) * | 2006-03-15 | 2011-09-07 | 国立大学法人東北大学 | 異常型プリオン蛋白質の濃縮方法、および除去方法 |
MX2009001079A (es) * | 2006-07-28 | 2009-02-10 | Adlyfe Inc | Sondas de peptido para diagnosis y terapeutica. |
US7601506B2 (en) * | 2006-07-28 | 2009-10-13 | Idexx Laboratories, Inc. | Identification of leucocytes bearing diagnostic markers for transmissible spongiform encephalopathies |
WO2008083972A2 (en) * | 2007-01-12 | 2008-07-17 | Alicon Ag | Method for removing prion protein |
EP2279203B1 (de) | 2008-04-25 | 2016-06-15 | University Of Saskatchewan | Prionenepitope und verwendungsverfahren dafür |
JP2011520108A (ja) * | 2008-04-30 | 2011-07-14 | ノバルティス アーゲー | 病原性配座異性体についてのアッセイ |
US20120009209A1 (en) * | 2010-06-10 | 2012-01-12 | The Regents Of The University Of California | Enrichment and purification of infectious prion proteins |
JP2013537971A (ja) * | 2010-09-13 | 2013-10-07 | アッヴィ・インコーポレイテッド | 高感度なモノクローナル抗体残留物検出アッセイ |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI90990C (fi) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
EP0658564B1 (de) | 1986-04-30 | 2002-01-16 | Igen International, Inc. | Elektrolumineszente Verbindungen und Zwischenprodukte zur Herstellung |
SU1529119A1 (ru) | 1987-04-20 | 1989-12-15 | Белорусский научно-исследовательский институт эпидемиологии и микробиологии | Способ определени нейровирусов в спинномозговой жидкости |
US4806627A (en) * | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
WO1992006220A1 (en) | 1990-10-05 | 1992-04-16 | President And Fellows Of Harvard College | Detection and isolation of ligands |
JPH06505962A (ja) | 1990-10-30 | 1994-07-07 | ラ ホヤ キャンサー リサーチ ファウンデーション | T−カドヘリン接着分子 |
DK0616613T3 (da) * | 1991-12-03 | 1999-09-27 | Proteus Molecular Design | Fragmenter af prionprotein |
US5646250A (en) * | 1992-04-17 | 1997-07-08 | Doheny Eye Institute | Cadherin polypeptides |
WO1993021302A1 (en) * | 1992-04-17 | 1993-10-28 | Doheny Eye Institute | Cadherin materials and methods |
US5597725A (en) * | 1992-04-17 | 1997-01-28 | Doheny Eye Institute | Cadherin-specific antibodies and hybridoma cell lines |
WO1993023432A1 (en) | 1992-05-15 | 1993-11-25 | New York University | Soluble prion polypeptides, and methods for detecting and purifying thereof |
US5276059A (en) | 1992-07-10 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of diseases associated with amyloid formation |
US5643781A (en) * | 1992-12-29 | 1997-07-01 | Doheny Eye Institute | DNA encoding protocadherin-42 |
US5798224A (en) * | 1992-12-29 | 1998-08-25 | Doheny Eye Institute | Nucleic acids encoding protocadherin |
US5679530A (en) | 1995-04-12 | 1997-10-21 | Ludwig Institute For Cancer Research | Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein |
US5948763A (en) * | 1995-06-07 | 1999-09-07 | New York University | Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
ES2218598T3 (es) * | 1995-09-14 | 2004-11-16 | The Regents Of The University Of California | Anticuerpo especifico del prpsc natural. |
US5750361A (en) * | 1995-11-02 | 1998-05-12 | The Regents Of The University Of California | Formation and use of prion protein (PRP) complexes |
EP0914614B1 (de) * | 1996-05-14 | 2003-09-03 | Winnacker, Ernst-Ludwig, Prof. | Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können |
CA2256312A1 (en) * | 1996-05-29 | 1997-12-04 | Mcgill University | Prion protein binding proteins and uses thereof |
EP0861900A1 (de) | 1997-02-21 | 1998-09-02 | Erziehungsdirektion Of The Canton Zurich | Immunologischer Nachweis von Prionen |
US5891641A (en) * | 1997-02-21 | 1999-04-06 | The Regents Of The University Of California | Assay for disease related conformation of a protein |
DE19741607A1 (de) | 1997-09-20 | 1999-03-25 | Prionics Ag | Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen |
US6165784A (en) | 1997-10-14 | 2000-12-26 | The United States Of America As Represented By The Secretary Of Agriculture | Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies |
DE69909442T2 (de) | 1998-02-20 | 2004-04-22 | The Regents Of The University Of California, Oakland | Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen |
US6211149B1 (en) * | 1998-08-03 | 2001-04-03 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors of formation of protease resistant prion protein |
GB2348203B (en) * | 1998-11-04 | 2002-06-19 | Imp College Innovations Ltd | Solube beta-forms of prion proteins, methods of preparation and use |
EP1194164B8 (de) * | 1999-06-23 | 2007-03-21 | IDEXX Laboratories Inc | Prion protein peptide und deren verwendung |
EP1210110A4 (de) * | 1999-06-29 | 2003-03-19 | Univ Mcgill | An prionprotein bindende proteine und deren verwendungen |
CA2405568A1 (en) * | 2000-04-05 | 2001-10-18 | North Carolina State University | Prion-binding peptidic ligands and methods of using same |
DE10230141B4 (de) * | 2002-07-04 | 2004-07-15 | Priontype Gmbh | Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) |
US20040072236A1 (en) | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
-
2002
- 2002-09-27 US US10/256,538 patent/US20040072236A1/en not_active Abandoned
-
2003
- 2003-09-25 WO PCT/US2003/030273 patent/WO2004029072A2/en active Search and Examination
- 2003-09-26 EP EP03754894A patent/EP1575989B1/de not_active Expired - Lifetime
- 2003-09-26 AT AT03754894T patent/ATE467124T1/de not_active IP Right Cessation
- 2003-09-26 CA CA002500120A patent/CA2500120A1/en not_active Abandoned
- 2003-09-26 JP JP2004539916A patent/JP4533750B2/ja not_active Expired - Fee Related
- 2003-09-26 DE DE60332488T patent/DE60332488D1/de not_active Expired - Lifetime
-
2006
- 2006-01-27 US US11/342,208 patent/US7435540B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2004029072A2 (en) | 2004-04-08 |
EP1575989A2 (de) | 2005-09-21 |
EP1575989B1 (de) | 2010-05-05 |
DE60332488D1 (de) | 2010-06-17 |
US7435540B2 (en) | 2008-10-14 |
CA2500120A1 (en) | 2004-04-08 |
WO2004029072A3 (en) | 2005-12-15 |
EP1575989A4 (de) | 2007-05-16 |
AU2003272695A1 (en) | 2004-04-19 |
US20060183156A1 (en) | 2006-08-17 |
JP2006507484A (ja) | 2006-03-02 |
JP4533750B2 (ja) | 2010-09-01 |
US20040072236A1 (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467124T1 (de) | Mit prp sp sc/sp wechselwirkende moleküle und deren verwendung | |
ATE541590T1 (de) | Modifizierte antikörper-fragmente | |
DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
CY1107453T1 (el) | Baff, σχετικοι δεσμευτικοι παραγοντες και χρηση αυτων στη διεγερση και αναστολη β-κυτταρων και ανοσοσφαιρινων σε ανοσοαποκρισεις | |
WO2005018424A3 (en) | Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits | |
ATE490275T1 (de) | Antikörper gegen interleukin-22 und verwendungen dafür | |
ATE373719T1 (de) | Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung | |
WO2005003171A3 (en) | Modified antibody fragments | |
DE69813158T2 (de) | Assays zur Bestimmung von Proteinfragmenten in biologischen Medien | |
ATE492563T1 (de) | Vollständige humane monoklonale antikörper gegen il-13 | |
DE60224291D1 (de) | System zur antikörperexpression und- synthese | |
DE502005009389D1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
ATE424560T1 (de) | Marker für neuromyelitis optica | |
ATE395082T1 (de) | Antikörper gegen krebsantigen tmeff2 und seine anwendungen | |
NO20053304L (no) | NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse | |
ATE300052T1 (de) | Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden | |
ATE309543T1 (de) | Natürlicher ligand von gpcr chemr23 und dessen verwendung | |
DE60033455D1 (de) | Menschlischer monoklonaler Antikörper gegen Ep-CAM und dessen Verwendung in Krebstherapie | |
ATE417605T1 (de) | Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität | |
DE69433243D1 (de) | Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit | |
WO2003027251A3 (en) | Novel molecules of the pyrin domain protein family and uses thereof | |
DE60332481D1 (de) | Peptide und deren verwendung in der behandlung von krankheiten des zentralen nervensystems | |
DE60334400D1 (de) | Neue polynukleotid- und polypeptidsequenzen und deren verwendungen | |
DE602005021322D1 (de) | An calciumbindende proteine | |
DE60218848D1 (de) | Verfahren zur trennung und/oder zum nachweis und/oder zur identifizierung und/oder zur quantifizierung von prionproteinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |